Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1976 1
1977 1
1979 1
1980 2
1981 3
1982 4
1983 6
1984 6
1985 5
1986 4
1987 13
1988 18
1989 17
1990 8
1991 15
1992 11
1993 3
1994 7
1995 6
1996 10
1997 6
1998 9
1999 2
2000 15
2001 9
2002 9
2003 13
2004 4
2005 10
2006 12
2007 17
2008 3
2009 9
2010 11
2011 10
2012 8
2013 10
2014 11
2015 7
2016 5
2017 7
2018 12
2019 1
2020 5
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

331 results
Results by year
Filters applied: . Clear all
Page 1
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.
Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, Asami K, Katakami N, Takada M, Yoshioka H, Shibata K, Kudoh S, Shimizu E, Saito H, Toyooka S, Nakagawa K, Fukuoka M; West Japan Oncology Group. Mitsudomi T, et al. Among authors: negoro s. Lancet Oncol. 2010 Feb;11(2):121-8. doi: 10.1016/S1470-2045(09)70364-X. Epub 2009 Dec 18. Lancet Oncol. 2010. PMID: 20022809 Clinical Trial.
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.
Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y, Fukuoka M. Ohe Y, et al. Among authors: negoro s. Ann Oncol. 2007 Feb;18(2):317-23. doi: 10.1093/annonc/mdl377. Epub 2006 Nov 1. Ann Oncol. 2007. PMID: 17079694 Free article. Clinical Trial.
Structural and functional characterization of nylon hydrolases.
Negoro S, Kato DI, Ohki T, Yasuhira K, Kawashima Y, Nagai K, Takeo M, Shibata N, Kamiya K, Shigeta Y. Negoro S, et al. Methods Enzymol. 2021;648:357-389. doi: 10.1016/bs.mie.2020.11.004. Epub 2020 Dec 29. Methods Enzymol. 2021. PMID: 33579412
Biodegradation of nylon oligomers.
Negoro S. Negoro S. Appl Microbiol Biotechnol. 2000 Oct;54(4):461-6. doi: 10.1007/s002530000434. Appl Microbiol Biotechnol. 2000. PMID: 11092619 Review.
[Treatment of small cell lung cancer].
Negoro S. Negoro S. Gan To Kagaku Ryoho. 2005 Jun;32(6):777-82. Gan To Kagaku Ryoho. 2005. PMID: 15984515 Review. Japanese.
Irinotecan in small-cell lung cancer--Japanese trials.
Fukuoka M, Masuda N, Kudoh S, Negoro S. Fukuoka M, et al. Among authors: negoro s. Oncology (Williston Park). 2000 Jul;14(7 Suppl 5):57-62. Oncology (Williston Park). 2000. PMID: 10981292 Free article. Review.
[Nogitecan hydrochloride].
Negoro S. Negoro S. Nihon Rinsho. 2002 May;60 Suppl 5:370-3. Nihon Rinsho. 2002. PMID: 12101691 Review. Japanese. No abstract available.
Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB-IIIA non-small cell lung cancer (WJTOG0101).
Yamaguchi M, Tada H, Mitsudomi T, Seto T, Yokoi K, Katakami N, Nakagawa K, Oda M, Ohta M, Sawa T, Yamashita M, Iked N, Saka H, Higashiyama M, Nomori H, Semba H, Negoro S, Chiba Y, Shimokawa M, Fukuoka M, Nakanishi Y; West Japan Thoracic Oncology Group (WJTOG). Yamaguchi M, et al. Among authors: negoro s. Int J Clin Oncol. 2021 Dec;26(12):2216-2223. doi: 10.1007/s10147-021-02012-9. Epub 2021 Aug 31. Int J Clin Oncol. 2021. PMID: 34463869 Clinical Trial.
331 results